Ventilatory neural drive in chronically hypercapnic patients with COPD: effects of sleep and nocturnal noninvasive ventilation

Author:

McCartney Alexandra,Phillips Devin,James MatthewORCID,Chan Olivia,Neder J. AlbertoORCID,de-Torres Juan P.ORCID,Domnik Nicolle J.ORCID,Crinion Sophie J.ORCID

Abstract

Sleep brings major challenges for the control of ventilation in humans, particularly the regulation of arterial carbon dioxide pressure (PaCO2). In patients with COPD, chronic hypercapnia is associated with increased mortality. Therefore, nocturnal high-level noninvasive positive-pressure ventilation (NIV) is recommended with the intention to reducePaCO2down to normocapnia. However, the long-term physiological consequences ofPaCO2“correction” on the mechanics of breathing, gas exchange efficiency and resulting symptoms (i.e.dyspnoea) remain poorly understood. Investigating the influence of sleep on the neural drive to breathe and its translation to the mechanical act of breathing is of foremost relevance to create a solid rationale for the use of nocturnal NIV. In this review, we critically discuss the mechanisms by which sleep influences ventilatory neural drive and mechanical consequences in healthy subjects and hypercapnic patients with advanced COPD. We then discuss the available literature on the effects of nocturnal NIV on ventilatory neural drive and respiratory mechanics, highlighting open avenues for further investigation.

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference125 articles.

1. World Health Organization (WHO) . The Top 10 Causes of Death. 2020. www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death Date last updated: 9 December 2020.

2. Global and regional estimates of COPD prevalence: systematic review and meta-analysis;Adeloye;J Glob Health,2015

3. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

4. Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries;Beran;Lancet Respir Med,2015

5. Treatment of respiratory failure in COPD;Budweiser;Int J Chron Obstruct Pulmon Dis,2008

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3